XML 38 R27.htm IDEA: XBRL DOCUMENT
v3.25.3

RESTRUCTURING CHARGES AND SEPARATION COSTS | 9 Months Ended
--- | ---
Sep. 30, 2025
Restructuring and Related Activities [Abstract] |
RESTRUCTURING CHARGES AND SEPARATION COSTS | RESTRUCTURING CHARGES AND SEPARATION COSTS RESTRUCTURING AND OTHER CHARGES. This table is inclusive of all restructuring charges in our segments and at Corporate & Other. Separately, in our reported segment results, significant, higher-cost restructuring programs, primarily related to the separations, are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate & Other.
RESTRUCTURING AND OTHER CHARGES | Three months ended September 30 |  | Nine months ended September 30 |
| 2025 | 2024 |  | 2025 | 2024 |
Workforce reductions | $ | 20 |  | $ | 3 |  |  | $ | 39 |  | $ | 110 |  |
Plant closures & associated costs and other asset write-downs | 2 |  | 45 |  |  | 12 |  | 70 |  |
Acquisition/disposition net charges and other | — |  | 328 |  |  | — |  | 366 |  |
| $ | 22 |  | $ | 376 |  |  | $ | 51 |  | $ | 546 |  |
Cost of equipment/services | $ | — |  | $ | 26 |  |  | $ | 3 |  | $ | 27 |  |
Selling, general and administrative expenses | 22 |  | 350 |  |  | 48 |  | 519 |  |
Total restructuring and other charges | $ | 22 |  | $ | 376 |  |  | $ | 51 |  | $ | 546 |  |
Restructuring and other cash expenditures(a) | $ | 9 |  | $ | 16 |  |  | $ | 64 |  | $ | 115 |  |
(a) Primarily related to employee severance payments. The restructuring liability as of September 30, 2025 and December 31, 2024 was $198 million and $242 million, respectively. For the three and nine months ended September 30, 2025, and 2024, restructuring and other charges for ongoing programs primarily included exit activities announced in the fourth quarter of 2022, reflecting lower Corporate & Other shared-service and footprint needs as a result of the GE HealthCare and GE Vernova spin-offs. Additionally, for the three and nine months ended September 30, 2024, restructuring and other charges included costs of $328 million and $363 million, respectively, for the settlement of the Sjunde AP-Fonden shareholder lawsuit. SEPARATION COSTS. In November 2021, the Company announced its plan to form three industry-leading, global public companies focused on the growth sectors of aerospace, healthcare and energy. As discussed in Note 2, we completed this plan with the spin of GE Vernova in the second quarter of 2024. Post-separation, we continue to incur operational and transition costs related to ongoing separation activities, including employee costs, professional fees, costs to establish certain stand-alone functions and information technology systems, and other transformation to transition to a stand-alone public company. These costs are presented as separation costs in our Statement of Operations. We incurred pre-tax separation costs of $53 million and $74 million, recognized $11 million and $61 million of net tax benefits and paid $56 million and $144 million in cash for the three months ended September 30, 2025 and 2024, respectively. For 2024, the net tax benefits included tax benefit of losses on separation related entity restructuring. We incurred pre-tax separation costs of $150 million and $408 million, recognized $31 million and $311 million of net tax benefits, and paid $202 million and $716 million in cash for the nine months ended September 30, 2025 and 2024, respectively. For 2024, the net tax benefits included deferred tax benefits associated with state tax attributes. The pre-tax separation costs specifically identifiable to GE HealthCare and GE Vernova are reflected in discontinued operations. For the three months ended September 30, 2025 and 2024, we incurred insignificant costs for both GE Healthcare and GE Vernova. Additionally, we had insignificant cash spend related to GE HealthCare and GE Vernova for the three months ended September 30, 2025, and for GE Vernova we paid $66 million in cash for the three months ended September 30, 2024. For the nine months ended September 30, 2025 and 2024, we incurred insignificant costs and cash spend related to GE HealthCare. For GE Vernova, we incurred insignificant costs and cash spend for the period ended September 30, 2025, and incurred pre-tax separation costs of $99 million, recognized $21 million of net tax benefit and paid $187 million in cash for the nine months ended September 30, 2024.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4.e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/420/tableOfContent Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration